Pharmacokinetic/pharmacodynamic correlation between teduglutide, an analog of GLP-2, and citrulline, a biomarker of small intestinal enterocyte functional mass in short bowel patients

被引:1
|
作者
Messing, Bernard
Mouksassi, Samer
Jeppesen, Palle Bekker
Joly, Francisca
Demchyshyn, Lidia
Cyran, J.
Marier, Jean-Francois
机构
[1] Hop Beaujon, Clichy La Garenne, France
[2] Pharsight Corp, Montreal, PQ, Canada
[3] Rigshosp, DK-2100 Copenhagen, Denmark
[4] NPS Pharmaceut, Bedminster, NJ USA
来源
关键词
D O I
10.14309/00000434-200809001-00275
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
275
引用
收藏
页码:S106 / S106
页数:1
相关论文
共 30 条
  • [1] Teduglutide, a GLP-2 analog enhances intestinal structure in short bowel syndrome (SBS) patients dependent on parenteral nutrition (PN)
    Tappenden, Kelly
    Pertkiewicz, Marek
    Gilroy, Richard
    Allard, Johane
    Kunecki, Marek
    Sauerwein, Hans
    Mc-Graw, Nancy
    Bekker, Palle
    Messing, Bernard
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S105 - S105
  • [2] Teduglutide, a Human Recombinant Analog of Glucagon-Like Peptide-2 (GLP-2), Increases Plasma Citrulline Levels in Patients With Short Bowel Syndrome
    Messing, Bernard
    Joly, Francisca
    Schwartz, Lauren K.
    Iyer, Kishore R.
    Chu, Henry
    Youssef, Nader
    GASTROENTEROLOGY, 2012, 142 (05) : S369 - S369
  • [3] Case Report: Morphologic and Functional Characteristics of Intestinal Mucosa in a Child With Short Bowel Syndrome After Treatment With Teduglutide: Evidence in Favor of GLP-2 Analog Safety
    Falco, Enrico Costantino
    Lezo, Antonella
    Calvo, Pierluigi
    Rigazio, Caterina
    Opramolla, Anna
    Verdun, Ludovica
    Cenacchi, Giovanna
    Pellegrini, Marianna
    Spada, Marco
    Canavese, Gabriella
    FRONTIERS IN NUTRITION, 2022, 9
  • [4] GLP-2 modulated genes in adult patients with Short Bowel Syndrome (SBS) treated with Teduglutide (TED)
    de Dreuille, Brune
    Nicolle, Remy
    Cazals-Hatem, Dominique
    Cros, Jerome
    Le Beyec-Le Bihan, Johanne
    Le Gall, Maude
    Bado, Andre
    Joly, Francisca
    TRANSPLANTATION, 2023, 107 (7S) : 34 - 34
  • [5] GLP-2 ANALOG TEDUGLUTIDE AND LIVER FIBROSIS: POST-HOC ANALYSIS OF LIVER CHEMISTRIES IN THE SHORT BOWEL SYNDROME WITH INTESTINAL FAILURE STEPS CLINICAL TRIALS
    Micic, Dejan
    Sullivan, Adam
    Kidd, Tanya
    Terreri, Brian
    Raphael, Bram
    HEPATOLOGY, 2021, 74 : 816A - 816A
  • [6] Teduglutide, a Recombinant Analog of GLP-2, Reduces Parenteral Support in Patients with Short Bowel Syndrome Regardless of Ultra-Short Remnant Bowel and/or No Colon-in-Continuity Anatomy.
    Fujioka, Ken
    Schneider, Stephane M.
    Li, Benjamin
    Youssef, Nader N.
    Pape, Ulrich-Frank
    Jeejeebhoy, Khursheed
    TRANSPLANTATION, 2015, 99 : S27 - S27
  • [7] GLP-2 analog Teduglutide in active Crohn's disease and short bowel syndrome: Confirmation of anti-inflammatory role and future perspectives
    Borghini, Raffaele
    Caronna, Roberto
    Donato, Giuseppe
    Picarelli, Antonio
    DIGESTIVE AND LIVER DISEASE, 2020, 52 (06) : 686 - 687
  • [8] Teduglutide, a glucagon-like peptide-2 (GLP-2) analog, improves fluid balance in short bowel syndrome (SBS) patients depending on parenteral support (PN)
    Jeppesen, Palle B.
    Messing, Bernard
    Pertkiewicz, Marek
    Cyran, Jane
    Demchyshyn, Lidia L.
    Kershner, Ronald
    GASTROENTEROLOGY, 2008, 134 (04) : A110 - A111
  • [9] Teduglutide, a novel GLP-2 analog, in the management of short bowel syndrome (SBS) patients dependent on parenteral nutrition: A multicenter, multinational placebo-controlled clinical trial
    O'Keefe, Stephen J.
    Gilroy, Richard
    Jeppesen, Palle B.
    Messing, Bernard
    Allard, Johane P.
    Seidner, Douglas L.
    Pertkiewicz, Marek
    Kapikian, Roxanne
    McGraw, Nancy
    Caminis, John
    GASTROENTEROLOGY, 2008, 134 (04) : A37 - A37
  • [10] Impaired meal-stimulated GLP-2 response in short bowel patients with intestinal failure.
    Jeppesen, PB
    Hartmann, B
    Holst, JJ
    Mortensen, PB
    GASTROENTEROLOGY, 1999, 116 (04) : A893 - A893